Results 11 to 18 of about 19 (18)
Neuroleptic malignant syndrome in Huntington disease
European Journal of Neurology, Volume 31, Issue 12, December 2024.Abstract Background and Purpose Despite the wide use of dopamine receptor blocking agents (DRBAs) in Huntington disease (HD), neuroleptic malignant syndrome (NMS) is rarely described in this population. The aim of this study was to assess NMS prevalence in a large cohort of HD patients and explore the main associated risk factors.
Antonio Funcis +6 more
wiley +1 more source
British Journal of Pharmacology, Volume 181, Issue 22, Page 4571-4592, November 2024.Chronic clozapine exposure leads to downregulation of 5‐HT receptors, but prompt discontinuation leads to transient upregulation of 5‐HT receptors via signalling of the AMPK‐PP2A pathway. Transient upregulation of 5‐HT2A receptors secondarily enhances tripartite synaptic transmission via activation of calcium‐induced calcium‐release.
Motohiro Okada +2 more
wiley +1 more source
Nanomedicine Therapies for Pediatric Diseases
WIREs Nanomedicine and Nanobiotechnology, Volume 16, Issue 5, September/October 2024.This review highlights the unique challenges in pediatric drug therapy and emphasizes the potential of nanomedicines in addressing these challenges, detailing their properties, Food and Drug Administration‐approved applications, and preclinical studies that may translate to clinical practice in treating pediatric diseases.
Shicheng Yang +4 more
wiley +1 more source
Mechanochemistry in Organic Synthesis: An Italian Journey through Innovations
European Journal of Organic Chemistry, Volume 27, Issue 30, August 12, 2024.The contribution of Italy to the development of mechanochemistry dates back to 1988 with the first studies on metal alloys. With the progress of time, it has flourished not only in the field of organic chemistry, but also in other scientific fields due to the enormous interest of Italian researchers in the various advantages brought by this technique ...
Francesco Basoccu +2 more
wiley +1 more source
Guideline for pharmacological treatment of schizophrenia 2022
Neuropsychopharmacology Reports, Volume 45, Issue 1, March 2025.
Japanese Society of Neuropsychopharmacology +1 more
wiley +1 more source
Nanotherapeutics for Alleviating Anesthesia‐Associated Complications
Advanced Science, Volume 11, Issue 15, April 17, 2024.Nanotechnology exhibits excellent performance in anesthesia‐associated toxicity via safety nano‐formulization design, alter their pharmacokinetics and higher pharmacodynamic activities of anesthetics toxicity. Abstract Current management of anesthesia‐associated complications falls short in terms of both efficacy and safety.
Bin Lu +3 more
wiley +1 more source
Myopathies associated with Streptococcus equi equi infection
Equine Veterinary Education, Volume 36, Issue 8, Page 400-402, August 2024.
Stephanie Valberg
wiley +1 more source
RESEARCH COMMUNICATIONS OF THE 34th ECVIM‐CA CONGRESS
Journal of Veterinary Internal Medicine, Volume 38, Issue 6, Page 3537-3694, November/December 2024.
wiley +1 more source